-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Cardinal Health, Raises Price Target to $170

Benzinga·05/02/2025 22:34:10
Listen to the news
UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $160 to $170.